Houston doctor resumes ivermectin push years after COVID controversy.
The gains look especially impressive amid deforestation due to record wildfires, which burned an area of Brazilian rainforest ...
Traws Pharma, Inc. (NASDAQ: TRAW) (“Traws Pharma”, “Traws” or “the Company”), a clinical-stage biopharmaceutical company ...
Traws Pharma, Inc. (NASDAQ: TRAW) shares reported sharp gains to begin Friday trade. The Newtown, Pa.-based company, a clinical-stage biopharmaceutical concern developing novel therapies to target ...
Traws Pharma, Inc. (NASDAQ: TRAW) ("Traws Pharma", "Traws" or "the Company"), a clinical-stage biopharmaceutical company developing novel therapies to target ...
Bacteria fend off invading viruses with molecular scissors that slice up viral DNA—a system called CRISPR that's become ...
Bruker Corporation today announced new NMR products and workflow solutions designed to expand performance, sensitivity, and ...
Bacteria fend off invading viruses with molecular scissors that slice up viral DNA - a system called CRISPR that's become ...
Detailed price information for Guardant Health Inc (GH-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results